Journal of Shanghai Jiao Tong University (Medical Science) ›› 2023, Vol. 43 ›› Issue (6): 781-787.doi: 10.3969/j.issn.1674-8115.2023.06.016
• Review • Previous Articles
CHENG Ran(), HU Jiajia, LI Biao()
Received:
2023-01-29
Accepted:
2023-05-04
Online:
2023-06-28
Published:
2023-06-28
Contact:
LI Biao
E-mail:chengran354@163.com;lb10363@rjh.com.cn
Supported by:
CLC Number:
CHENG Ran, HU Jiajia, LI Biao. Advances in the application of 18F-FDG PET/CT radiomics for diagnosis, treatment and prognosis prediction of lymphoma[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(6): 781-787.
Add to citation manager EndNote|Ris|BibTeX
URL: https://xuebao.shsmu.edu.cn/EN/10.3969/j.issn.1674-8115.2023.06.016
1 | SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. |
2 | LIU W P, LIU J M, SONG Y Q, et al. Burden of lymphoma in China, 1990—2019: an analysis of the global burden of diseases, injuries, and risk factors study 2019[J]. Aging, 2022, 14(7): 3175-3190. |
3 | MILLER K D, NOGUEIRA L, DEVASIA T, et al. Cancer treatment and survivorship statistics, 2022[J]. CA Cancer J Clin, 2022, 72(5): 409-436. |
4 | CHESON B D, FISHER R I, BARRINGTON S F, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification[J]. J Clin Oncol, 2014, 32(27): 3059-3068. |
5 | BARRINGTON S F, KLUGE R. FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas[J]. Eur J Nucl Med Mol Imaging, 2017, 44(Suppl 1): S97-S110. |
6 | CHESON B D, MEIGNAN M. Current role of functional imaging in the management of lymphoma[J]. Curr Oncol Rep, 2021, 23(12): 144. |
7 | JIANG H, LI A, JI Z Y, et al. Role of radiomics-based baseline PET/CT imaging in lymphoma: diagnosis, prognosis, and response assessment[J]. Mol Imaging Biol, 2022, 24(4): 537-549. |
8 | CASALI M, LAURI C, ALTINI C, et al. State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation[J]. Clin Transl Imaging, 2021, 9(4): 299-339. |
9 | MAYERHOEFER M E, MATERKA A, LANGS G, et al. Introduction to radiomics[J]. J Nucl Med, 2020, 61(4): 488-495. |
10 | VAN TIMMEREN J E, CESTER D, TANADINI-LANG S, et al. Radiomics in medical imaging-"how-to" guide and critical reflection[J]. Insights Imaging, 2020, 11(1): 91. |
11 | VISVIKIS D, CHEZE LE REST C, JAOUEN V, et al. Artificial intelligence, machine (deep) learning and radio(geno)mics: definitions and nuclear medicine imaging applications[J]. Eur J Nucl Med Mol Imaging, 2019, 46(13): 2630-2637. |
12 | DE JESUS F M, YIN Y, MANTZOROU-KYRIAKI E, et al. Machine learning in the differentiation of follicular lymphoma from diffuse large B-cell lymphoma with radiomic [18F]FDG PET/CT features[J]. Eur J Nucl Med Mol Imaging, 2022, 49(5): 1535-1543. |
13 | AIDE N, TALBOT M, FRUCHART C, et al. Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma[J]. Eur J Nucl Med Mol Imaging, 2018, 45(5): 699-711. |
14 | MAYERHOEFER M E, UMUTLU L, SCHÖDER H. Functional imaging using radiomic features in assessment of lymphoma[J]. Methods, 2021, 188: 105-111. |
15 | MAYERHOEFER M E, RIEDL C C, KUMAR A, et al. [18F]FDG-PET/CT radiomics for prediction of bone marrow involvement in mantle cell lymphoma: a retrospective study in 97 patients[J]. Cancers, 2020, 12(5): 1138. |
16 | KONG Z R, JIANG C D, ZHU R Z, et al. 18F-FDG-PET-based radiomics features to distinguish primary central nervous system lymphoma from glioblastoma[J]. Neuroimage Clin, 2019, 23: 101912. |
17 | OU X J, ZHANG J, WANG J, et al. Radiomics based on 18F-FDG PET/CT could differentiate breast carcinoma from breast lymphoma using machine-learning approach: a preliminary study[J]. Cancer Med, 2020, 9(2): 496-506. |
18 | ZHU S, XU H, SHEN C Y, et al. Differential diagnostic ability of 18F-FDG PET/CT radiomics features between renal cell carcinoma and renal lymphoma[J]. Q J Nucl Med Mol Imaging, 2021, 65(1): 72-78. |
19 | SIBILLE L, SEIFERT R, AVRAMOVIC N, et al. 18F-FDG PET/CT uptake classification in lymphoma and lung cancer by using deep convolutional neural networks[J]. Radiology, 2020, 294(2): 445-452. |
20 | LOVINFOSSE P, FERREIRA M, WITHOFS N, et al. Distinction of lymphoma from sarcoidosis on 18F-FDG PET/CT: evaluation of radiomics-feature-guided machine learning versus human reader performance[J]. J Nucl Med, 2022, 63(12): 1933-1940. |
21 | FROOD R, CLARK M, BURTON C, et al. Utility of pre-treatment FDG PET/CT-derived machine learning models for outcome prediction in classical Hodgkin lymphoma[J]. Eur Radiol, 2022, 32(10): 7237-7247. |
22 | AKHTARI M, MILGROM S A, PINNIX C C, et al. Reclassifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentation[J]. Blood, 2018, 131(1): 84-94. |
23 | MILGROM S A, ELHALAWANI H, LEE J, et al. A PET radiomics model to predict refractory mediastinal Hodgkin lymphoma[J]. Sci Rep, 2019, 9(1): 1322. |
24 | LUE K H, WU Y F, LIU S H, et al. Prognostic value of pretreatment radiomic features of 18F-FDG PET in patients with Hodgkin lymphoma[J]. Clin Nucl Med, 2019, 44(10): e559-e565. |
25 | MAYERHOEFER M E, RIEDL C C, KUMAR A, et al. Radiomic features of glucose metabolism enable prediction of outcome in mantle cell lymphoma[J]. Eur J Nucl Med Mol Imaging, 2019, 46(13): 2760-2769. |
26 | LISSON C S, LISSON C G, MEZGER M F, et al. Deep neural networks and machine learning radiomics modelling for prediction of relapse in mantle cell lymphoma[J]. Cancers, 2022, 14(8): 2008. |
27 | WANG H X, ZHAO S N, LI L, et al. Development and validation of an 18F-FDG PET radiomic model for prognosis prediction in patients with nasal-type extranodal natural killer/T cell lymphoma[J]. Eur Radiol, 2020, 30(10): 5578-5587. |
28 | PARVEZ A, TAU N, HUSSEY D, et al. 18F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin's lymphoma as predictors of treatment outcome and survival[J]. Ann Nucl Med, 2018, 32(6): 410-416. |
29 | AIDE N, FRUCHART C, NGANOA C, et al. Baseline 18F-FDG PET radiomic features as predictors of 2-year event-free survival in diffuse large B cell lymphomas treated with immunochemotherapy[J]. Eur Radiol, 2020, 30(8): 4623-4632. |
30 | JIANG C, LI A, TENG Y, et al. Optimal PET-based radiomic signature construction based on the cross-combination method for predicting the survival of patients with diffuse large B-cell lymphoma[J]. Eur J Nucl Med Mol Imaging, 2022, 49(8): 2902-2916. |
31 | JIANG C, HUANG X J, LI A, et al. Radiomics signature from [18F]FDG PET images for prognosis predication of primary gastrointestinal diffuse large B cell lymphoma[J]. Eur Radiol, 2022, 32(8): 5730-5741. |
32 | EERTINK J J, VAN DE BRUG T, WIEGERS S E, et al. 18F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma[J]. Eur J Nucl Med Mol Imaging, 2022, 49(3): 932-942. |
33 | FROOD R, CLARK M, BURTON C, et al. Discovery of pre-treatment FDG PET/CT-derived radiomics-based models for predicting outcome in diffuse large B-cell lymphoma[J]. Cancers, 2022, 14(7): 1711. |
34 | ZHANG X H, CHEN L, JIANG H, et al. A novel analytic approach for outcome prediction in diffuse large B-cell lymphoma by [18F]FDG PET/CT[J]. Eur J Nucl Med Mol Imaging, 2022, 49(4): 1298-1310. |
35 | COTTEREAU A S, NIOCHE C, DIRAND A S, et al. 18F-FDG PET dissemination features in diffuse large B-cell lymphoma are predictive of outcome[J]. J Nucl Med, 2020, 61(1): 40-45. |
36 | EERTINK J J, ZWEZERIJNEN G J C, CYSOUW M C F, et al. Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features[J]. Eur J Nucl Med Mol Imaging, 2022, 49(13): 4642-4651. |
37 | JIMENEZ J E, DAI D, XU G F, et al. Lesion-based radiomics signature in pretherapy 18F-FDG PET predicts treatment response to ibrutinib in lymphoma[J]. Clin Nucl Med, 2022, 47(3): 209-218. |
38 | HU X B, GUO R, CHEN J N, et al. Coarse-to-fine adversarial networks and zone-based uncertainty analysis for NK/T-cell lymphoma segmentation in CT/PET images[J]. IEEE J Biomed Health Inform, 2020, 24(9): 2599-2608. |
39 | GUO R, HU X B, SONG H M, et al. Weakly supervised deep learning for determining the prognostic value of 18F-FDG PET/CT in extranodal natural killer/T cell lymphoma, nasal type[J]. Eur J Nucl Med Mol Imaging, 2021, 48(10): 3151-3161. |
[1] | HOU Shumin, SHAO Jingbo. Research progress in clinical characteristics, diagnosis and prognosis of TdT-negative lymphoblastic lymphoma/acute lymphoblastic leukemia [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(1): 120-124. |
[2] | HU Zeyu, ZHOU Cheng, YANG Lin, MA Xiaoyan, XIAO Haijuan, SI Hailong. Monomorphic epitheliotropic intestinal T-cell lymphoma: a case with recurrent gastrointestinal hemorrhage [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(1): 132-136. |
[3] | JIANG Zhenglin, GAO Yunge, WU Hao. Study on the expression of B-cell leukemia/lymphoma 11B in the organ of Corti during mice cochlea development [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(10): 1361-1374. |
[4] | Jun-lin HE, Qing LU, Xin XU, Shu-dong HU. Value of CT radiomic features in preoperative prediction of cervical lymph node metastasis in patients with papillary thyroid carcinoma [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(9): 1233-1239. |
[5] | Zi-hao LIU, Wen-fang TANG, Hui WANG. Research progress in amino acid PET imaging of pediatric brain tumors [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(7): 949-952. |
[6] | Tong TONG, Xing QIN, Fei XIE, Ying-ying JIANG, Jian-bo SHI, Jian-jun ZHANG. USP47 induces cisplatin resistance in head and neck squamous cell carcinoma by up-regulation of anti-apoptotic proteins [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(4): 434-441. |
[7] | Gao-yang LI, Ji-feng JIANG, Chuan-xu LIU, Wen-hao ZHANG, Yang ZHU, Yu-jie MA, Rong TAO. A pilot study on the efficacy and safety of anlotinib in the treatment of refractory natural killer/T-cell lymphoma [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(2): 196-201. |
[8] | NI Xue-ping1, 2, LI Xian-hua2, XIN Xiao2, WU Sheng-jia1, 2, SONG Ting1, HE Yang2, ZHENG Xin2. Current status of self-perceived burden and related factors in the patients with non-Hodgkin's lymphoma [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(6): 856-862. |
[9] | WANG Hai-yan, YOU Zhi-wen, SHOU Yi, MENG Qing-yuan, CHEN Hui-qian, ZHAO Jun. Application of 18F-FDG PET/CT-guided percutaneous biopsy to differential diagnosis of peritoneal thickening diseases [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(5): 646-650. |
[10] | HE Bin, LI Qi-yue, HONG Ling, WU Yuan-yuan, TENG Xiao-ming, TANG Chuan-ling. Effect of SIRT1 on H2O2-induced oxidative damage in human ovarian granulosa cells [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(12): 1591-1597. |
[11] | LUO Gang, CUI Yong-chen, CAO Yue, ZHANG Jun-feng. Effect of surgical trauma on postoperative cognitive function and cerebral glucose metabolism in type 2 diabetic mice [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(11): 1468-1472. |
[12] | JIANG Tao1, 2, SHI Qing1, XU Peng-peng1, CHENG Shu1, WANG Li1, ZHAO Wei-li1. Clinicopathology and prognosis analysis of adrenal lymphoma [J]. , 2019, 39(9): 1032-. |
[13] | ZHU Yin-jie, WANG Yan-qing, PAN Jia-hua, DONG Bai-jun, XUE Wei. PET/CT for guidance of lymphadenectomy of high-risk prostate cancer in patients with chronic lymphocytic leukemia: 1 case report [J]. , 2019, 39(4): 440-. |
[14] | WANG Jia-lin, JI Di, CHEN Xiang, YANG Bo, YU Lin. Effect of miR-218-2-3P on proliferation and apoptosis of NK/T-cell lymphomatargeting SIN3A [J]. , 2019, 39(12): 1394-. |
[15] | XIE Wei1, JIANG Xu-feng2, ZHAO Wei-li1, WANG Li1. Prognostic evaluation of different PET/CT reading methods in Hodgkin lymphoma and diffused large B-cell lymphoma [J]. , 2018, 38(8): 954-. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||